The increased number of Leydig cells by di(2-ethylhexyl) phthalate comes from the differentiation of stem cells into Leydig cell lineage in the adult rat testis

Toxicology. 2013 Apr 5:306:9-15. doi: 10.1016/j.tox.2013.01.021. Epub 2013 Feb 4.

Abstract

The objective of the present study is to determine whether di(2-ethylhexyl) phthalate (DEHP) exposure at adulthood increases rat Leydig cell number and to investigate the possible mechanism. 90-day-old Long-Evans rats were randomly divided into 3 groups, and were gavaged with the corn oil (control) or 10 or 750 mg/kg DEHP daily for 7 days, and then received an intraperitoneal injection of 75 mg/kg ethane dimethanesulfonate (EDS) to eliminate Leydig cells. Serum testosterone concentrations were assessed by RIA, and the mRNA levels of Leydig cell genes were measured by qPCR. EDS eliminated all Leydig cells in the control testis on day 4 post-EDS, as judged by undetectable serum testosterone level and no 3β-hydroxysteroid dehydrogenase positive (3β-HSD(pos)) cells in the interstitium. However, in DEHP-treated groups, there were detectable serum testosterone concentrations and some oval-shaped 3β-HSD(pos) cells in the interstitium. These 3β-HSD(pos) cells were not stained by the antibody against 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1), a marker for Leydig cells at a more advanced stage. The disappearance of mRNAs of Leydig cell biomarkers including Lhcgr, Cyp11a1, Cyp17a1, Insl3 and Hsd11b1 in the control testis was observed on day 4 post-EDS. However, there were detectable concentrations of Lhcgr, Cyp11a1 and Cyp17a1 mRNAs but undetectable concentrations of Insl3, Hsd17b3 and Hsd11b1 in the DEHP-treated testes, indicating that these 3β-HSD(pos) cells were newly formed progenitor Leydig cells. The mRNA level for nestin (Nes, biomarker for stem Leydig cells) was significantly increased in the control testis on day 4 post-EDS, but not in the DEHP treated testes, suggesting that these nestin positive stem cells were differentiated into progenitor Leydig cells in the DEHP-treated testes. The present study suggests that DEHP increases the differentiation of stem cells into progenitor Leydig cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 11-beta-Hydroxysteroid Dehydrogenase Type 1 / analysis
  • 11-beta-Hydroxysteroid Dehydrogenase Type 1 / metabolism
  • Animals
  • Cell Differentiation / drug effects
  • Cell Lineage
  • Diethylhexyl Phthalate / toxicity*
  • Immunohistochemistry
  • Intermediate Filament Proteins / genetics
  • Intermediate Filament Proteins / metabolism
  • Leydig Cells / cytology
  • Leydig Cells / drug effects*
  • Leydig Cells / metabolism
  • Leydig Cells / ultrastructure
  • Luteinizing Hormone / blood
  • Male
  • Mesylates / pharmacology
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / metabolism
  • Nestin
  • Plasticizers / toxicity*
  • RNA / chemistry
  • RNA / genetics
  • Random Allocation
  • Rats
  • Rats, Long-Evans
  • Reverse Transcriptase Polymerase Chain Reaction
  • Testis / cytology
  • Testis / drug effects*
  • Testis / metabolism
  • Testosterone / blood

Substances

  • Intermediate Filament Proteins
  • Mesylates
  • Nerve Tissue Proteins
  • Nes protein, rat
  • Nestin
  • Plasticizers
  • Testosterone
  • RNA
  • Luteinizing Hormone
  • Diethylhexyl Phthalate
  • 11-beta-Hydroxysteroid Dehydrogenase Type 1
  • ethylene dimethanesulfonate